National Institute of Dental & Craniofacial Research; Notice of Closed Meeting, 1063-1064 [2010-96]
Download as PDF
Federal Register / Vol. 75, No. 5 / Friday, January 8, 2010 / Notices
opportunity announcements; (2) conduct of
Secondary Peer Review of extramural
research grants, cooperative agreements, and
contracts applications received in response to
the funding opportunity announcements as it
relates to the Center’s programmatic balance
and mission; (3) submission of secondary
review recommendations to the Center
Director of applications to be considered for
funding support; (4) review of research
portfolios; and (5) review of program
proposals. The board shall provide guidance
on the National Center of Injury Prevention
and Control’s programs and research
activities by conducting scientific peer
review of intramural research and programs
within the National Center for Injury
Prevention and Control; by ensuring
adherence to Office of Management and
Budget requirements for intramural peer
review; and by monitoring the overall
direction, focus, and success of the National
Center for Injury Prevention and Control.
Matters to be Discussed: As this meeting of
the Board of Scientific Counselors, the board
will be discussing the upcoming portfolio
topics, activities promoting the Injury
Research Agenda, and other scientific
matters.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information: Dr.
Gwendolyn Cattledge, PhD, MSEH, Deputy
Associate Director for Science and the
Designated Federal Officer for the Board of
Scientific Counselors, NCIPC, CDC, 4770
Buford Highway, NE., Mailstop F–63,
Atlanta, Georgia 30341, Telephone (770)
488–1430.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Gary J. Johnson,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2010–22 Filed 1–7–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
pwalker on DSK8KYBLC1PROD with NOTICES
Clinical Laboratory Improvement
Advisory Committee (CLIAC)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following committee
meeting:
Times and Dates:
8:30 a.m.–5 p.m., February 9, 2010.
8:30 a.m.–3 p.m., February 10, 2010.
Place: CDC, 1600 Clifton Road, NE.,
Tom Harkin Global Communications
VerDate Nov<24>2008
16:14 Jan 07, 2010
Jkt 220001
Center, Building 19, Room 232,
Auditorium B, Atlanta, Georgia 30333.
Online Registration Required: In order
to expedite the security clearance
process at the CDC Roybal Campus
located on Clifton Road, all CLIAC
attendees are required to register for the
meeting online at least 14 days in
advance at https://wwwn.cdc.gov/cliac/
default.aspx by clicking the ‘‘Register for
a Meeting’’ link and completing all
forms according to the instructions
given. Please complete all the required
fields before submitting your
registration and submit no later than
January 26, 2010.
Status: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 100
people.
Purpose: This Committee is charged
with providing scientific and technical
advice and guidance to the Secretary of
Health and Human Services, the
Assistant Secretary for Health, and the
Director, CDC, regarding the need for,
and the nature of, revisions to the
standards under which clinical
laboratories are regulated; the impact on
medical and laboratory practice of
proposed revisions to the standards; and
the modification of the standards to
accommodate technological advances.
Matters To Be Discussed: The agenda
will include updates from the CDC, the
Centers for Medicare & Medicaid
Services, and the Food and Drug
Administration; a report from the CLIAC
Biochemical Genetic Testing Workgroup
and discussion of the Workgroup’s
proposals related to good laboratory
practices for biochemical genetic
testing; and presentations and
discussions related to electronic health
records and electronic transmission of
laboratory information.
Agenda items are subject to change as
priorities dictate.
Providing Oral or Written Comments:
It is the policy of CLIAC to accept
written public comments and provide a
brief period for oral public comments
whenever possible.
Oral Comments: In general, each
individual or group requesting to make
an oral presentation will be limited to
a total time of five minutes (unless
otherwise indicated). Speakers must
also submit their comments in writing
for inclusion in the meeting’s Summary
Report. To assure adequate time is
scheduled for public comments,
individuals or groups planning to make
an oral presentation should, when
possible, notify the contact person
below at least one week prior to the
meeting date.
Written Comments: For individuals or
groups unable to attend the meeting,
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
1063
CLIAC accepts written comments until
the date of the meeting (unless
otherwise stated). However, the
comments should be received at least
one week prior to the meeting date so
that the comments may be made
available to the Committee for their
consideration and public distribution.
Written comments, one hard copy with
original signature, should be provided
to the contact person below. Written
comments will be included in the
meeting’s Summary Report.
Contact Person for Additional
Information: Nancy Anderson, Chief,
Laboratory Practice Standards Branch,
Division of Laboratory Systems,
National Center for Preparedness,
Detection, and Control of Infectious
Diseases, CDC, 1600 Clifton Road, NE.,
Mailstop F–11, Atlanta, Georgia 30333;
telephone (404) 498–2741; fax (404)
498–2219; or via e-mail at
Nancy.Anderson@cdc.hhs.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
Notices pertaining to announcements of
meetings and other committee
management activities, for CDC and the
Agency for Toxic Substances and
Disease Registry.
Dated: December 30, 2009.
Gary J. Johnson,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2010–100 Filed 1–7–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
E:\FR\FM\08JAN1.SGM
08JAN1
1064
Federal Register / Vol. 75, No. 5 / Friday, January 8, 2010 / Notices
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; Review U13.
Date: February 11, 2010.
Time: 2 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892, (Virtual
Meeting)
Contact Person: Mary Kelly, Scientific
Review Officer, Scientific Review Branch,
National Inst of Dental & Craniofacial
Research, NIH 6701 Democracy Blvd, room
672, MSC 4878, Bethesda, md 20892–4878,
301–594–4809, mary_kelly@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: January 4, 2010.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–96 Filed 1–7–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
pwalker on DSK8KYBLC1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Cancer Biomarkers Study Section.
Date: February 1–2, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Alexandria Old Town, 1767
King Street, Alexandria, VA 22314.
Contact Person: Lawrence Ka-Yun Ng,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6152,
MSC 7804, Bethesda, MD 20892, 301–435–
1719, ngkl@csr.nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Radiation Therapeutics and Biology
Study Section.
VerDate Nov<24>2008
16:14 Jan 07, 2010
Jkt 220001
Date: February 1–2, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Bo Hong, PhD, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 6194, MSC 7804, Bethesda, MD
20892, 301–435–5879, hongb@csr.nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Basic Mechanisms of Cancer
Therapeutics Study Section.
Date: February 1–2, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz Carlton Hotel, 1150 22nd Street,
NW., Washington, DC 20037.
Contact Person: Lambratu Rahman, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214,
MSC 7804, Bethesda, MD 20892, 301–451–
3493, rahmanl@csr.nih.gov.
Name of Committee: Oncology 1—Basic
Translational Integrated Review Group;
Cancer Etiology Study Section.
Date: February 1–2, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel, 1515 Rhode Island
Avenue, NW., Washington, DC 20005.
Contact Person: Cathleen L. Cooper, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4208,
MSC 7812, Bethesda, MD 20892, 301–443–
4512, cooperc@csr.nih.gov.
Name of Committee: Digestive, Kidney and
Urological Systems Integrated Review Group;
Hepatobiliary Pathophysiology Study
Section.
Date: February 1–2, 2010.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin Ave.,
Bethesda, MD 20814.
Contact Person: Rass M. Shayiq, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2182,
MSC 7818, Bethesda, MD 20892, (301) 435–
2359, shayiqr@csr.nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group; Biological Rhythms
and Sleep Study Section.
Date: February 1, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Bahia Resort Hotel, 998 West
Mission Bay Dr., San Diego, CA 92109.
Contact Person: Michael Selmanoff, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1208,
MSC 7844, Bethesda, MD 20892, 301–435–
1119, mselmanoff@csr.nih.gov.
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
Name of Committee: Bioengineering
Sciences & Technologies Integrated Review
Group; Nanotechnology Study Section.
Date: February 1–2, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Bahia Resort Hotel, 998 West
Mission Bay Drive, San Diego, CA 92109.
Contact Person: Joseph D. Mosca, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5158,
MSC 7808, Bethesda, MD 20892, (301) 408–
9465, moscajos@csr.nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group; Somatosensory and
Chemosensory Systems Study Section.
Date: February 1–2, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Bahia Resort Hotel, 998 West
Mission Bay Drive, San Diego, CA.
Contact Person: Bernard F. Driscoll, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5184,
MSC 7844, Bethesda, MD 20892, (301) 435–
1242, driscolb@csr.nih.gov.
Name of Committee: Oncology 1—Basic
Translational Integrated Review Group;
Tumor Microenvironment Study Section.
Date: February 1–2, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Ritz-Carlton, 1150 22nd Street,
NW., Washington, DC 20037.
Contact Person: Eun Ah Cho, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6202,
MSC 7804, Bethesda, MD 20892, (301) 451–
4467, choe@csr.nih.gov.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group; Child Psychopathology and
Developmental Disabilities Study Section.
Date: February 1–2, 2010.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Hotel, 2401 M Street,
NW., Washington, DC 20037.
Contact Person: Jane A. DoussardRoosevelt, PhD, Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 3184, MSC 7848, Bethesda, MD 20892,
(301) 435–4445, doussarj@csr.nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group;
Neuroendocrinology, Neuroimmunology, and
Behavior Study Section.
Date: February 2–3, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Bahia Resort Hotel, 998 West
Mission Bay Drive, San Diego, CA 92109.
Contact Person: Michael Selmanoff, PhD,
Scientific Review Officer, Center for
E:\FR\FM\08JAN1.SGM
08JAN1
Agencies
[Federal Register Volume 75, Number 5 (Friday, January 8, 2010)]
[Notices]
[Pages 1063-1064]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-96]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Dental & Craniofacial Research; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
[[Page 1064]]
Name of Committee: National Institute of Dental and Craniofacial
Research Special Emphasis Panel; Review U13.
Date: February 11, 2010.
Time: 2 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, One Democracy Plaza, 6701
Democracy Boulevard, Bethesda, MD 20892, (Virtual Meeting)
Contact Person: Mary Kelly, Scientific Review Officer,
Scientific Review Branch, National Inst of Dental & Craniofacial
Research, NIH 6701 Democracy Blvd, room 672, MSC 4878, Bethesda, md
20892-4878, 301-594-4809, mary_kelly@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.121, Oral
Diseases and Disorders Research, National Institutes of Health, HHS)
Dated: January 4, 2010.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-96 Filed 1-7-10; 8:45 am]
BILLING CODE 4140-01-P